Many researchers and research organisations recognise the value of engaging with consumers with the consistent message being that people who have a personal experience of cancer bring a unique perspective and a wealth of diversity, knowledge, and capabilities to research and health initiatives. In addition, funding bodies almost always insist on researchers demonstrating this perspective has been sought for applications to be considered favourably. However, some hesitation still exists and connecting effectively is often easier said than done. Can a lay person really understand research concepts and provide meaningful input? This session will provide examples of working partnerships and what it takes for individual researchers, research organisations, and consumers to work collaboratively to bring better health outcomes for people affected by cancer.
This breakfast session is supported by COSA and ANZBCTG
Chair: Rick de Boer
Neoadjuvant treatment of breast cancer is becoming an integral part of modern multidisciplinary cancer management. Join us for breakfast with international expert Dr Laura Esserman, as she covers the clinical evidence and more practical aspects of neoadjuvant treatment in HER2-positive breast cancer. Following this, a multidisciplinary panel will discuss how this evidence translates in to clinical practice in Australia, now and in to the future.
Governments throughout the world are exploring ways by which affordable access to innovative cancer medicines can be expedited. A number of years ago Canada implemented a specialised pan-Canadian Oncology Drug Review (pCODR), outside of the regular reimbursement process. Bill Evans is an oncologist and former member of the pCODR Expert Review Committee (pERC). This symposium will be an opportunity to examine some of the challenges for access to medicines in Australia, and understand how clinicians can play a role in supporting timely and affordable cancer treatment.
Dr Bill Evans - former member of Pan-Canadian Oncology Drugs Review
Dr Deme Karikios - Medical Oncology Group of Australia
10:10 AM Panel Discussion
11:40 AM Interviews with MBC patients Herb Wagner (founder "A Man's Pink") and Robert Fincher (BCNA)
12:00 PM Q&A panel discussion
This session follows a highly successful format used at previous meetings. It is designed to provide a forum for discussion of the complex issues which arise in the care of patients with breast cancer. The facilitator will present a series of challenging clinical cases and engage members of the multidisciplinary panel in discussion. There will also be opportunities for members of the audience to contribute to the discussion.
- Boon Chua – Radiation oncologist
- Laura Esserman – Surgeon
- Sunil Lakhani – Translational researcher
- Kelly Phillips – Medical oncologist
- Janine Porter-Steele – Nurse
- Michelle Reintals – Radiologist
- Claudia Rutherford – Research Fellow, Quality of Life
- Leonie Young - Consumer
5:15 PM Panel Discussion
5:00 PM Q&A panel discussion
5:15 PM Panel discussion
Including the Tom Reeve Oration – Fran Boyle
and ANZBCTG Awards